Pharmaceutical Nanotechnology (PNT)

Pharmaceutical Nanotechnology is a leading international journal published by Bentham Science Publishers that focuses on the cutting edge of nanotechnology as applied to pharmaceutical and biomedical sciences. First published in 2013, the journal provides a forum for peer-reviewed original research, in-depth reviews, technical notes and thematic collections that showcase innovations in nanoscale systems designed for therapeutic and diagnostic purposes. Nanotechnology in the pharmaceutical context involves controlling materials and devices below 1 µm in size, where physical and chemical properties often differ dramatically from bulk materials—enabling improved drug loading, targeted delivery, controlled release, enhanced stability, and reduced toxicity. The journal highlights studies on the design, synthesis and detailed characterization of nanomaterials, as well as biological evaluations such as in vitro and in vivo testing, toxicological profiling and early-stage clinical assessments. It also features research on nanotechnology-enabled diagnostics, such as nanosensors and imaging agents, and interdisciplinary work that bridges pharmaceutical science with materials engineering, molecular biology and medical applications. By publishing rigorous research on nano-enabled drug delivery systems, carrier platforms (e.g., liposomes, polymeric nanoparticles), and advanced characterization methods, Pharmaceutical Nanotechnology plays a key role in advancing both theoretical understanding and practical translation of nanomedicine innovations. With a bimonthly publishing schedule, the journal ensures regular dissemination of new knowledge and developments in this rapidly advancing field.

Pharmaceutical Nanotechnology (PNT) is :-

• International, Peer-Reviewed, Open Access, Refereed, Biomedical Engineering, Pharmaceutical Science, Nanomaterial design and synthesis for pharmaceutical use, Advanced characterization techniques for nanoscale systems, Biological evaluation and in vivo studies related to nanotherapeutics, Toxicological and safety assessments of nano-formulations , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2211-7385, E-ISSN: 2211-7393, Established: 2014,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE